duloxetine 60 MG Delayed Release Oral Capsule
1 INDICATIONS AND USAGE Duloxetine delayed-release capsules USP are indicated for the treatment of: • Major Depressive disorder in adults • Generalized Anxiety disorder in adults and pediatric patients 7 years of age and older • Diabetic peripheral neuropathic pain in adults • Fibromyalgia in adults • Chronic Musculoskeletal Pain in adults Additional pediatric use information is approved for Eli Lilly and Company, Inc.’s CYMBALTA (duloxetine) delayed-release capsules. However, due to Eli Lilly and Company Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. Duloxetine is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of the following conditions: Major Depressive disorder (MDD) in adults ( 1 ) Generalized Anxiety disorder (GAD) in adults and pediatric patients 7 years of age and older ( 1 ) Diabetic peripheral neuropathic pain (DPNP) in adults ( 1 ) Fibromyalgia (FM) in adults ( 1 ) Chronic Musculoskeletal Pain in adults ( 1 )
Sun Pharmaceutical Industries, Inc.
CAPSULE GREEN 383 383
Related Pills
duloxetine 30 MG Delayed Release Oral Capsule
Sun Pharmaceutical Industries, Inc.
duloxetine 20 MG Delayed Release Oral Capsule
Sun Pharmaceutical Industries, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
DULOXETINE delayed-release capsules USP are available in the following strengths, colors, imprints, and presentations: Features Strengths 20 mg 30 mg 60 mg Body color green white green Cap color green blue blue Cap imprint 381 382 383 Body imprint 381 382 383 capsule Size 4 3 1 Presentations and NDC Codes Bottles of 30 with child-resistant closure 47335-381-83 47335-382-83 47335-383-83 Bottles of 60 with child-resistant closure 47335-381-86 - - Bottles of 90 with child-resistant closure - 47335-382-81 - Bottles of 100 with child-resistant closure 47335-381-88 47335-382-88 47335-383-88 Bottles of 100 47335-381-08 47335-382-08 47335-383-08 Bottles of 1000 47335-381-18 47335-382-18 47335-383-18 Unit dose blisters of 100 47335-381-61 47335-382-61 47335-383-61 16.2 Storage and Handling Store
DULOXETINE delayed-release capsules USP at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Dispense in a tightly closed container.
More pills like CAPSULE 383 383